http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109232734-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-075 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 |
filingDate | 2017-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109232734-B |
titleOfInvention | Monoclonal antibody specifically binding canine adenovirus, pharmaceutical composition, kit and application thereof |
abstract | The invention provides a variable region sequence of a mouse monoclonal antibody specifically binding to canine adenovirus, and an antibody specifically binding to canine adenovirus, and the antibody can be used for preparing a kit and a pharmaceutical composition. The kit provided by the invention overcomes the problem of low detection sensitivity in the prior art, avoids the phenomena of missed detection and false negative, can detect various targets, and has the advantages of rapidness, simplicity, convenience and accuracy; the pharmaceutical composition can effectively prevent and treat diseases caused by CAV-1 and CAV-2. |
priorityDate | 2017-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 279.